Vice President, Biometrics

Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world.

It is Kardigan’s mission to develop multiple targeted treatments in parallel that bring people with cardiovascular diseases to the cures they deserve.

Led by Tassos Giannakakos, Jay Edelberg, M.D. and Bob McDowell, Ph.D., Kardigan’s co‑founders have reunited after leading Myo Kardia to discover and develop mavacamten, the first cardiac myosin inhibitor, resulting in an acquisition by Bristol Myers Squibb in 2020.

We have a cutting‑edge discovery and translational research platform, a pipeline of late‑stage candidates, and an industry‑leading team that is driven to improve the lives of patients.

At Kardigan, we are motivated by our values which guide how we work, interact, and achieve our goals.
Driven by patients and their families
, we are deeply committed to improving the lives of patients and prioritizing their needs above all else. We believe in being authentic
—leading with truth to bring out the best in others by creating an environment where every person knows they will be fully accepted. With an eagerness to learn
, we encourage the highest levels of curiosity and are open to changing our minds. We are committed to winning as a team with urgency, excellence, and intention, and support each other no matter what role we play or where we sit. Lastly, we strive to enable the impossible because patients are counting on us. We are not afraid to take risks to unlock innovation and advance scientific discoveries.

These values are the foundation of our work, empowering us to make a real difference, every day.

Kardigan is a 4 day on-site company (Mon - Thurs)

The Vice President, Head of Biometrics leads the strategic, scientific, and operational direction of all biostatistics, statistical programming, analytics and clinical data management functions across the clinical development portfolio rating in a lean, fast‑paced environment, the incumbent will lead biometrics support across all clinical programs and actively contribute to the clinical development and regulatory strategy and submissions. This role is a member of the Development Operations & Biometrics leadership team, and, as such, contributes to portfolio strategy, evidence generation, and long‑range planning.

• Provide expert biometrics and statistical guidance for study design, go/no‑go decisions, and overall clinical portfolio optimization
• Serve as a key member and thought partner on clinical development plan, molecule strategy and disease area strategy, partnering closely with Medical, Clinical Operations, Safety, and Regulatory to ensure biometrics insights inform trial design, operational planning, and launch strategy
• Develop the biometrics function and strategy aligned with the organization’s clinical development goals. Lead the recruitment, onboarding, and management of direct reports and external vendors and consultants
• Oversee integrated data strategies across trials and ensure delivery of the statistical analysis strategy for clinical development programs (including target product profiles), clinical development plans, endpoint strategy, statistical analysis plans (SAPs), reports and manuscripts, and statistical analysis required to support development
• Ensure data interpretation and statistical analysis support high‑integrity decision making and regulatory submissions
• Act as the primary biometrics representative for regulatory interactions and serve as a thought partner on regulatory submission activities. Ensure that all data and information submitted are in compliance with regulations (eg, ICH E6/E9, 21 CFR Part 11, GCP) and global data standards & regulatory requirements for the submission
• Champion modern analytics, automation, RWE integration, and data visualization tools to improve efficiency and data quality
• Drive the selection and optimization of data systems and scalable governance & SOP for data flow, data integrity, and oversight of CRO/vendor deliverables
• Drive the organization’s data‑driven culture, enabling rapid, high‑quality…